There are four key components of an AGP:
- Median
- 25th–75th Percentile
- 5th–95th Percentile
- Target Glucose Range
Each of these elements tells a clear story about your patients’ glucose control and variability over a selected time period.
Each of these elements tells a clear story about your patients’ glucose control and variability over a selected time period.
The ‘average’ (middle) point of all glucose levels that shows ‘what usually happens’ during a day.2 Look at whether it is in the target glucose range and how much it swings up and down throughout the day.
This band indicates where glucose levels are ‘half the time’. Look at width of the band throughout the day. The wider this band is, the more variable the glucose levels are day-to-day.2
This band indicates more ‘occasional’ high or low glucose levels. Look at areas where the band is widest, this indicates more day-to-day variation at these times.2
This is the corridor where glucose levels should be as much as possible. According to international consensus, the target glucose range is usually 3.9 mmol/L–10 mmol/L for adults with type 1 and type 2 diabetes who are not pregnant, not older, or at risk.1
✓ AGP is a visually impactful way to quickly identify times of greater risk of hypoglycaemia or unwanted glucose variability.2
✓ The visual format of the AGP allows the eye to quickly focus on areas that may need review and these can be assessed in terms of how significant they are by their timing, duration and how low glucose has fallen.2
✓ You can use the elements of the AGP in a systematic and straightforward way to help identify trends in glucose control. This includes not only the areas that may require remedial action, but also the parts of each day that reveal when glucose is in range and you are able to reinforce and encourage behaviour choices.2
LibreView is a secure, cloud-based diabetes management system. It provides both healthcare professionals and patients with access to a consistent set of clear, intuitive reports that make it easier and faster to discover patterns and trends.
With the AGP report on LibreView you can:
Explore our training resources to help you to
help your patients understand the Ambulatory
Glucose Profile.
References & Disclaimers
Images are for illustrative purposes only. Not real patient or data.
1. Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. (2019);42(8):1593-1603.
2. Gibb, F. W., Jennings, P., Leelarathna, L., & Wilmot, E. et al. AGP in Daily Clinical Practice: A guide for use with the Freestyle Libre Flash Glucose Monitoring System. British Journal of Diabetes. Retrieved June 30, 2022, from https://doi.org/10.15277/bjd.2020.240
₼ The LibreView website is only compatible with certain operating systems and browsers. Please check www.LibreView.com for additional information.
The "Yes" link below will take you to a website other than Abbott Laboratories. Links to other websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the content of such websites or any link contained in such websites. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site.
Do you want to leave this page?
This is a product-specific website intended for HCPs of the European Union and the UK only. If you live in another country, please contact your local Abbott office to obtain the correct product information for your country of residence.